Cardiovascular Market Research Reports & Industry Analysis

Caused by heart and/or blood-vascular system disorders, cardiovascular (CDV) diseases kill almost 17 million people annually. The cardiovascular market can be divided the following key segments: cardiac surgery, cardiac rhythm management (abbreviated as CRM) and interventional cardiology. There is a wide range of products on offer in the market: defibrillators, introducers, catheters, pacemakers, among others.

The growth of the cardiovascular market is driven by the aging population, rising incidence of chronic CDV, innovations and technology advancements in the cardiovascular industry and constantly improving treatment capabilities. The USA is the largest cardiovascular market, with AstraZeneca , Merck & Co. , Bristol-Myers Squibb (BMS), Novartis , Sanofi-Aventis and Pfizerbeing amid the most prominent market participants.

Comprehensive assessment of the cardiovascular market at various geographical scales and over different time spans is provided in the research reports found under this catalogue. Data demand and supply trends, research and development activities, and leading market players are at hand in the reports. Moreover, future prospects for the market are disclosed in the research reports.

Found 361 publications
Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain) US$ 1,750.00

... , France, Italy, UK, Spain) Summary GBI Research’s report, “Market Snapshot: Transcatheter Heart Valve 2007 to 2020 - Europe (Germany, France, Italy, UK, Spain)” provides ... on market size for the transcatheter heart valves Annualized sales data by revenue for the 2007–2020 period and company share data by ...

Aug, 2014 27 pages
Cardiovascular Risk Factors-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Cardiovascular Risk Factors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Cardiovascular Risk ...

Aug, 2014
Cardiovascular Inflammation-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Cardiovascular Inflammation-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Cardiovascular Inflammation. This ...

Aug, 2014
Cardiomyopathy-Pipeline Insights, 2014 US$ 1,250.00

SUMMARY DelveInsight’s,“ Cardiomyopathy-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Cardiomyopathy. This report provides information ...

Aug, 2014
South Africa Interventional Cardiology Market Trends and Forecast To 2019 US$ 2,100.00

This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in South Africa through 2019. The ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

May, 2014 45 pages
South Africa Heart Valve and Repair Market Trends and Forecast To 2019 US$ 2,100.00

... key market trends, market forecasts and competitive scenario of the cardiovascular heart valve and repair in South Africa through 2019. The product categories covered in this report include: Heart Valve Annuloplasty Rings Scope The report highlights historic and forecasted market ...

May, 2014 30 pages
China Interventional Cardiology Market Analysis - Size, Share, Growth, Trends and Forecast Through 2006 - 2019 US$ 2,100.00

This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in China through 2019. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

May, 2014 45 pages
China Heart Valve and Repair Market Analysis, Size, Share, Growth, Trends and Forecast Through 2006 - 2019 US$ 2,100.00

... key market trends, market forecasts and competitive scenario of the cardiovascular heart valve and repair in China through 2019. The product categories covered in this report include: Heart Valve Annuloplasty Rings Scope The report highlights historic and forecasted market size ...

May, 2014 30 pages
Canada Interventional Cardiology Market Opportunity and Growth Trends Forecast Till 2019 US$ 2,100.00

This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in Canada through 2019. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

May, 2014 45 pages
Canada Heart Valve and Repair Market Opportunity and Growth Trends Forecast Till 2019 US$ 2,100.00

... key market trends, market forecasts and competitive scenario of the cardiovascular heart valve and repair in Canada through 2019. The product categories covered in this report include: Heart Valve Annuloplasty Rings Scope The report highlights historic and forecasted market size ...

May, 2014 30 pages
Australia Joint Reconstruction Market Analysis - Size, Share, Growth, Trends and Forecast Through 2006 - 2019 US$ 2,100.00

This research report provides key market trends, market forecasts and competitive scenario of the joint reconstruction in Australia through 2019. The product ... comparison for product categories, historic and forecast through 2019. Market share of companies. Average selling price ($) for each product type ( ...

May, 2014 52 pages
Australia Interventional Cardiology Market Forecast and Opportunity Assessment, 2006 - 2019 US$ 2,100.00

This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in Australia through 2019. The product ... revenues & unit sales, average selling price, growth rates, and company market shares. Highlights and compares key product categories for growth ...

May, 2014 45 pages
Australia Heart Valve and Repair Market Forecast and Opportunity Assessment, 2006 - 2019 US$ 2,100.00

... key market trends, market forecasts and competitive scenario of the cardiovascular heart valve and repair in Australia through 2019. The product categories covered in this report include: Heart Valve Annuloplasty Rings Scope The report highlights historic and forecasted market ...

May, 2014 30 pages
Asia Pacific Cardiovascular Devices Market Forecast To 2019 US$ 4,200.00

... report provides critical market data for cardiovascular devices and its product categories for the Asia Pacific region and its ... ) Biological Heart Valve (Bioprosthetic Heart Valve (BHV) Annuloplasty Rings Cardiovascular Monitoring Systems ECG Monitoring Equipment (Electrocardiogram) ECG Stress Testing ...

May, 2014 166 pages
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries US$ 4,995.00

... of Key Patent Expiries Summary GBI Research, the leading business intelligence provider, has released its latest research, '‘Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries'’, which provides in-depth ...

Jun, 2014 91 pages
Heart Attack - Pipeline Review, H1 2014 US$ 2,000.00

... Summary Global Markets Direct’s, ‘Heart Attack - Pipeline Review, H1 2014’, provides an overview of the Heart Attack’s therapeutic pipeline. This report provides ... & other developmental activities The report reviews key players involved in the therapeutics development for Heart Attack and enlists all their ...

Apr, 2014 47 pages
France Cardiac Assist Procedures Outlook to 2020 US$ 175.00

... ’s new report, 'France Cardiac Assist Procedures Outlook to 2020', provides key procedures data on the France Cardiac Assist Procedures. The report ... models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most ...

May, 2014 22 pages
Cardiovascular Deals and Alliances of 2013 US$ 1,495.00

The Cardiovascular Deals and Alliances of 2013 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered ... signed by bigpharma and bigbiotech, and most active bigpharma. Where the deal has an agreement contract published at the SEC a link provides online ...

Aug, 2014 200 pages
Sectoral Capsule-The Heart of the Matter-Cardiovascular Market in India US$ 250.00

The capsule reports are concise information about the industry; and the opportunities & challenges that it carries. It gives the past as well as ... of the industry with all relevant inputs in place. The dynamics that propel the sector, namely, opportunities, competition, infrastructure investment and regulatory ...

Jan, 2014 16 pages
Ventricular Tachycardia Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... and data relating to the clinical trials on Ventricular Tachycardia. It includes an overview of the trial numbers and their recruitment status as per the ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Dec, 2013 74 pages
Ventricular Fibrillation Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... and data relating to the clinical trials on Ventricular Fibrillation. It includes an overview of the trial numbers and their recruitment status as per the ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Dec, 2013 60 pages
Venous Thromboembolism Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... and data relating to the clinical trials on Venous Thromboembolism. It includes an overview of the trial numbers and their recruitment status as per the ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Dec, 2013 125 pages
Thromboembolism Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... Summary GlobalData's clinical trial report, 'Thromboembolism Global Clinical Trials Review, H2, 2013' provides data on the Thromboembolism clinical trial scenario. This ... and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / ...

Dec, 2013 175 pages
Regurgitation Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... 2013 Summary GlobalData's clinical trial report, 'Regurgitation Global Clinical Trials Review, H2, 2013' provides data on the Regurgitation clinical trial scenario. This ... and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities ...

Dec, 2013 87 pages
Mitral Regurgitation Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... and data relating to the clinical trials on Mitral Regurgitation. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Dec, 2013 63 pages
Hypoxemia Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... 2013 Summary GlobalData's clinical trial report, 'Hypoxemia Global Clinical Trials Review, H2, 2013' provides data on the Hypoxemia clinical trial scenario. This ... type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / ...

Dec, 2013 63 pages
Chronic Stable Angina Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... Review, H2, 2013' provides data on the Chronic Stable Angina clinical trial scenario. This report provides elemental information and data relating ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Dec, 2013 69 pages
Bradycardia Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... 2013 Summary GlobalData's clinical trial report, 'Bradycardia Global Clinical Trials Review, H2, 2013' provides data on the Bradycardia clinical trial scenario. This ... type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities ...

Dec, 2013 62 pages
Atrial Flutter Global Clinical Trials Review, H2, 2013 US$ 2,500.00

... and data relating to the clinical trials on Atrial Flutter. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Dec, 2013 120 pages
Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use US$ 3,500.00

... GBI Research has released its pharmaceutical research, "Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue ... restraints that have had and are expected to have a significant impact upon the market Key licensing and co-development agreements in the ...

Nov, 2013 93 pages
Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat US$ 3,500.00

... Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat Summary GBI Research has released its pharmaceutical research, "Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat", which provides ...

Nov, 2013 106 pages
Vascular Dysfunction - Pipeline Review, H2 2013 US$ 2,000.00

... , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vascular Dysfunction. Vascular Dysfunction - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s ...

Nov, 2013 35 pages
MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts US$ 6,495.00

MediPoint: Peripheral Vascular Stents - Global Analysis and Market Forecasts Summary Endovascular therapies such as stenting have been widely adopted to treat ... and infrapopliteal arteries in the lower extremity? Bare metal and covered stents have been on the market for many years; however, unmet needs ...

Apr, 2013 402 pages
Physician Views: How have cardiologists, internal medicine specialists and general practitioners reacted to the new AHA/ACC cholesterol management guidelines US$ 645.00

... . Discussing the commercial opportunity for the PCSK9 inhibitors, a number of analysts have pointed out, however, that initial uptake of these new products will ... with the PCSK9 inhibitors. This week’s Physician Views poll will ask US-based cardiologists, general practioners and internal medicine specialists a ...

Nov, 2013
India Interventional Cardiology Market Trends Until 2018 US$ 2,000.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in India through 2018. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

Apr, 2012 18 pages
France Interventional Cardiology Market Trends Until 2018 US$ 2,000.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in France through 2018. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

Apr, 2012 18 pages
China Interventional Cardiology Market Trends Until 2018 US$ 2,000.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in China through 2018. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

Apr, 2012 18 pages
Canada Interventional Cardiology Market Trends Until 2018 US$ 2,000.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in Canada through 2018. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

Apr, 2012 18 pages
Canada Cardiovascular Surgery Market Trends Until 2018 US$ 2,000.00

... This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular surgery in Canada through 2018. The product ... comparison for product categories, historic and forecast through 2018. Market share of companies. Average selling price ($) for each product type ( ...

Apr, 2012 18 pages
Australia Interventional Cardiology Market Trends Until 2018 US$ 2,000.00

... research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in Australia through 2018. The product ... Devices (ACDs) Scope The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth ...

Apr, 2012 18 pages
UK Market for Peripheral Vascular Devices Through 2018 US$ 2,100.00

... Description This research report provides key market trends, market forecasts and competitive scenario of the peripheral vascular devices (PVD) in the UK through ... Scope The report highlights historic and forecasted Market size in terms of revenues & unit sales, average selling price, growth rates, and ...

Oct, 2013 31 pages
UK Market for Interventional Cardiology Through 2018 US$ 2,100.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in the UK through 2018. The ... (ACDs) Scope The report highlights historic and forecasted Market size in terms of revenues & unit sales, average selling price, growth rates, and ...

Oct, 2013 48 pages
Spain Heart Valve and Repair Market Outlook and Trends Till 2018 US$ 2,100.00

... key market trends, market forecasts and competitive scenario of the cardiovascular heart valve and repair in Spain through 2018. The product categories covered in this report include: Heart Valve Annuloplasty Rings Scope The report highlights historic and forecasted Market size ...

Oct, 2013 23 pages
North America Cardiovascular Devices Market Assessment and Forecasts To 2018 US$ 4,200.00

... Intelligence report provides critical market data for cardiovascular devices and its product categories for the North American region and ... and 2012 to 2018. Recent events and developments Cardiovascular Devices Market Segmentation Cardiac Assist Devices Total Artificial Heart Ventricular Assist ...

Oct, 2013 186 pages
Japan Market for Peripheral Vascular Devices Through 2018 US$ 2,100.00

... research report provides key market trends, market forecasts and competitive scenario of the peripheral vascular devices (PVD) in Japan through 2018. The ... PTA Balloon Grafts Scope The report highlights historic and forecasted Market size in terms of revenues & unit sales, average selling price, growth ...

Oct, 2013 31 pages
Japan Market for Interventional Cardiology Through 2018 US$ 2,100.00

... This research report provides key market trends, market forecasts and competitive scenario of the Interventional Cardiology in Japan through 2018. The product ... comparison for product categories, historic and forecast through 2018. Market share of companies. Average selling price ($) for each product type ...

Oct, 2013 48 pages
Heart Attack - Pipeline Review, H2 2013 US$ 2,000.00

... and discontinued projects. It also reviews key players involved in the therapeutic development for Heart Attack. Heart Attack - Pipeline Review, Half Year is ... news and deals relating to the products. Reasons to buy Identify and understand important and diverse types of therapeutics under development for ...

Oct, 2013 37 pages
Cardiac Fibrosis - Pipeline Review, H2 2013 US$ 2,000.00

... discontinued projects. It also reviews key players involved in the therapeutic development for Cardiac Fibrosis. Cardiac Fibrosis - Pipeline Review, Half Year ... news and deals relating to the products. Reasons to buy Identify and understand important and diverse types of therapeutics under development for ...

Oct, 2013 43 pages
Physician Views: How do European cardiologists perceive oral anticoagulants versus warfarin? – Is Eliquis, Pradaxa or Xarelto their favoured option? US$ 645.00

... is expected to double over the next 12 months. This week's FirstWord Physician Views poll will ask: How do the clinical profiles of oral anticoagulants compare with warfarin? How does the clinical profile of Eliquis compare to other oral anticoagulants? Which product – Eliquis, ...

Sep, 2013
The Top 25 Manufacturers Of Point-Of-Care Diagnostics For Cardiovascular Medicine US$ 234.00

... Products, Technology, Disease Areas, Parent Company, Year Established, Number of Employees and Turnover. Report Target Market: 1) Point-Of-Care Manufacturing Companies Usage: competitive/financial analysis and strategic partner/alliance identification. 2) Point-Of-Care Suppliers This report is perfect ...

Jun, 2012 60 pages
1 2 3 4 5 >
Skip to top